Suicide Research Today is a free monthly online journal that collates and summarizes the latest research about Suicide, including details on depression, causes, prevention, treatment, help.

Cholesterol metabolism and suicidality in Smith-Lemli-Opitz syndrome carriers.

Lalovic A, Merkens L, Russell L, Arsenault-Lapierre G, Nowaczyk MJ, Porter FD, Steiner RD, Turecki G

McGill Group for Suicide Studies, Douglas Hospital Research Centre, 6875 LaSalle Blvd., Verdun, Quebec H4H 1R3, Canada.

OBJECTIVE: The authors examined the relationship between cholesterol metabolism and suicidality in carriers of Smith-Lemli-Opitz syndrome and their families. This population has a partial deficiency in 7-dehydrocholesterol reductase (DHCR7), the enzyme that catalyzes the last step in cholesterol biosynthesis. METHOD: Suicidal behavior, depression, misuse of alcohol and drugs, and family history of psychopathology, including attempted or completed suicide, were assessed by structured interview in 51 carriers of Smith-Lemli-Opitz syndrome and 54 matched comparison subjects. RESULTS: There were significantly more suicide attempters and completers among the biological relatives of Smith-Lemli-Opitz syndrome carriers than comparison subjects, but family history of psychopathology did not significantly differ between the groups. More suicide attempts were reported among Smith-Lemli-Opitz syndrome carriers than among the comparison subjects. CONCLUSIONS: These results, based on a unique study design, provide additional evidence supporting the relationship between cholesterol metabolism and suicidal behavior.

Published 29 October 2004 in Am J Psychiatry, 161(11): 2123-6.
Full-text of this article is available online (may require subscription).

© 2004-2008 Suicide Research Today. All Rights Reserved.